Does Dr. ARMAND SCHACHTER have financial conflicts of interest?

Dr. ARMAND SCHACHTER (MD) has received a total of $427,563 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $427,563 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ARMAND SCHACHTER?

According to CMS Open Payments data, Dr. ARMAND SCHACHTER received funding from OTSUKA AMERICA PHARMACEUTICAL ($85,477), AXSOME THERAPEUTICS ($83,680), and ABBVIE ($69,814).

Does Dr. ARMAND SCHACHTER receive research grants or speaking fees?

Dr. ARMAND SCHACHTER has received $427,563 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ARMAND SCHACHTER

MDReal-Time Hydrated

Specialty: Psychiatry & Neurology, Psychiatry

Practice Location: BIRMINGHAM, AL 35244

NPI Number: 1295784312

LIFETIME INDUSTRY VALUE

$427,563

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. SCHACHTER is a verified Psychiatry & Neurology, Psychiatry practitioner based in BIRMINGHAM, AL.

Between 2021 and 2024, Dr. SCHACHTER had an overall industry promotional and research financial footprint of $427,563 as recorded in the federal CMS Open Payments database.

$427,563 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. SCHACHTER's primary funding source is OTSUKA AMERICA PHARMACEUTICAL, which accounts for $85,477 (representing 20% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OTSUKA AMERICA PHARMACEUTICAL

Rank 1

$85,477

20%

AXSOME THERAPEUTICS

Rank 2

$83,680

19.6%

ABBVIE

Rank 3

$69,814

16.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.